News
The triangular fibrocartilage complex is a critical structure in the wrist that provides stability to the distal radioulnar ...
Objective To determine whether monitoring facial nerve motor-evoked potentials (FNMEPs) elicited by transcranial electrical stimulation during microvascular decompression (MVD) for hemifacial spasm ...
ROCK HILL, S.C. - 3D Systems (NYSE:DDD), currently trading at $1.39 with a market capitalization of $188 million, announced Thursday that its bioprinting technology has enabled FDA approval for a ...
Combining TISSIUM’s expertise and proprietary biomorphic programable polymers with 3D Systems’ ground-breaking regenerative medicine bioprinting technologies has resulted in the successful development ...
The medical device utilizes TISSIUM’s proprietary biomorphic programmable polymers combined with 3D Systems’ bioprinting technology to create high-resolution, elastomeric biodegradable implants for ...
Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage 3D Systems’ bioprinting system ...
3D Systems and TISSIUM achieve FDA approval for a groundbreaking 3D-printed bioabsorbable device for peripheral nerve repair.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results